Your browser is no longer supported. Please, upgrade your browser.
Settings
HAE Haemonetics Corporation daily Stock Chart
HAE [NYSE]
Haemonetics Corporation
Index- P/E54.66 EPS (ttm)2.07 Insider Own1.00% Shs Outstand50.70M Perf Week-2.65%
Market Cap5.70B Forward P/E32.22 EPS next Y3.51 Insider Trans-19.53% Shs Float50.28M Perf Month11.25%
Income106.10M PEG5.47 EPS next Q0.68 Inst Own98.50% Short Float2.01% Perf Quarter25.60%
Sales902.50M P/S6.31 EPS this Y42.10% Inst Trans0.05% Short Ratio2.45 Perf Half Y15.61%
Book/sh13.18 P/B8.58 EPS next Y43.36% ROA7.90% Target Price118.29 Perf Year-4.31%
Cash/sh5.54 P/C20.41 EPS next 5Y10.00% ROE17.40% 52W Range63.41 - 126.74 Perf YTD-1.53%
Dividend- P/FCF47.64 EPS past 5Y35.40% ROI9.60% 52W High-10.73% Beta0.55
Dividend %- Quick Ratio1.30 Sales past 5Y1.70% Gross Margin48.50% 52W Low78.43% ATR3.62
Employees3004 Current Ratio2.20 Sales Q/Q-17.10% Oper. Margin15.20% RSI (14)60.91 Volatility2.60% 3.60%
OptionableYes Debt/Eq0.69 EPS Q/Q30.70% Profit Margin11.80% Rel Volume0.44 Prev Close112.55
ShortableYes LT Debt/Eq0.44 EarningsNov 04 BMO Payout0.00% Avg Volume411.81K Price113.14
Recom1.70 SMA204.14% SMA5012.49% SMA20016.52% Volume180,806 Change0.52%
Nov-05-20Upgrade Barrington Research Mkt Perform → Outperform $106
May-06-20Downgrade Barrington Research Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Jan-10-20Initiated Needham Buy $138
Aug-07-19Reiterated Barrington Research Outperform $116 → $139
May-14-19Upgrade Raymond James Mkt Perform → Outperform $110
May-08-19Reiterated Barrington Research Outperform $112 → $116
Aug-09-18Reiterated Barrington Research Outperform $90 → $118
Feb-07-18Reiterated Barrington Research Outperform $57 → $71
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-08-17Reiterated Barrington Research Outperform $48 → $57
Aug-08-17Upgrade Barrington Research Mkt Perform → Outperform $48
Jul-13-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Feb-07-17Downgrade Barrington Research Outperform → Mkt Perform
Nov-08-16Upgrade Barrington Research Mkt Perform → Outperform $41
Nov-07-16Reiterated The Benchmark Company Hold $32 → $34
Sep-20-16Downgrade CJS Securities Market Outperform → Market Perform
Aug-15-16Downgrade Sidoti Buy → Neutral
Aug-02-16Reiterated The Benchmark Company Hold $28 → $32
Aug-02-16Reiterated Jefferies Buy $32 → $40
Dec-01-20 10:52AM  
Nov-06-20 02:28PM  
Nov-05-20 10:34AM  
08:44AM  
Nov-04-20 07:30AM  
07:11AM  
06:15AM  
06:00AM  
Oct-28-20 12:32PM  
Oct-06-20 04:15PM  
Oct-02-20 08:36PM  
Sep-09-20 04:53PM  
Sep-08-20 08:08PM  
Sep-03-20 11:31AM  
Aug-07-20 06:45AM  
Aug-05-20 09:52AM  
07:37AM  
Aug-04-20 07:30AM  
07:28AM  
06:00AM  
Jul-28-20 12:32PM  
Jul-24-20 06:45AM  
Jul-22-20 05:57PM  
Jul-09-20 08:53PM  
Jul-06-20 04:15PM  
Jun-30-20 04:15PM  
Jun-08-20 10:08AM  
Jun-05-20 09:47AM  
Jun-03-20 06:45AM  
01:10AM  
May-28-20 04:18PM  
May-26-20 12:39AM  
May-11-20 08:03AM  
May-06-20 11:33AM  
May-05-20 09:01PM  
May-04-20 04:41PM  
01:36PM  
11:02AM  
09:08AM  
Apr-28-20 12:33PM  
Apr-24-20 09:05AM  
Apr-17-20 01:13PM  
Apr-16-20 12:10PM  
Apr-06-20 09:09AM  
Apr-03-20 08:00AM  
Apr-02-20 06:45AM  
Mar-30-20 04:15PM  
12:00PM  
Mar-26-20 04:52PM  
Mar-18-20 06:47AM  
Mar-09-20 09:20AM  
Mar-05-20 11:30AM  
Mar-03-20 09:22AM  
Mar-02-20 10:42AM  
Feb-18-20 08:52AM  
Feb-11-20 07:59AM  
Feb-07-20 11:30AM  
Feb-06-20 09:58PM  
Feb-05-20 10:51AM  
Feb-04-20 07:30AM  
06:00AM  
Feb-03-20 10:58AM  
Jan-28-20 12:31PM  
Jan-27-20 04:46PM  
Jan-23-20 10:48AM  
09:01AM  
Jan-22-20 10:44AM  
10:07AM  
10:05AM  
Jan-21-20 09:21AM  
09:04AM  
08:17AM  
Jan-20-20 09:49AM  
09:39AM  
07:34AM  
Jan-17-20 08:42AM  
07:10AM  
Jan-16-20 10:01AM  
09:43AM  
07:01AM  
Jan-15-20 10:18AM  
06:48AM  
Jan-14-20 10:01AM  
09:27AM  
06:30AM  
Jan-13-20 10:03AM  
09:42AM  
09:40AM  
07:30AM  
Jan-10-20 08:38AM  
Jan-09-20 10:19AM  
07:20AM  
05:52AM  
Jan-08-20 09:23AM  
09:00AM  
Jan-07-20 10:11AM  
10:08AM  
09:35AM  
09:09AM  
07:56AM  
Haemonetics Corporation, a healthcare company, provides hematology products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldstein DanVP, Corporate ControllerOct 26Sale106.0010010,6001,749Oct 28 05:02 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 26Sale106.001,161123,06611,337Oct 28 04:59 PM
Basil Michelle LEVP and General CounselOct 23Sale106.5818119,29115,992Oct 26 04:55 PM
Llorens JosepSVP, Global ManufacturingSep 08Sale88.711018,9604,254Sep 10 05:04 PM
ABERNATHY ROBERT EDirectorAug 11Buy80.934,000323,72012,048Aug 12 06:04 PM
Simon, ChristopherPresident & CEOJun 30Sale87.795,084446,324365,310Jul 02 04:20 PM
Basil Michelle LEVP and General CounselJun 16Sale91.0213,4361,223,00616,173Jun 16 06:19 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 16Sale91.0212,6141,148,16212,498Jun 16 06:16 PM
Goldstein DanVP, Corporate ControllerJun 16Sale91.533,040278,2511,849Jun 16 05:55 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 16Sale91.536,869628,7204,487Jun 16 05:53 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 15Option Exercise41.642,889120,29815,361Jun 16 05:53 PM
Basil Michelle LEVP and General CounselJun 15Sale87.7110,578927,79629,609Jun 16 06:19 PM
Simon, ChristopherPresident & CEOJun 15Sale87.7145,7234,010,364370,394Jun 16 05:51 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 15Sale88.808,422747,86511,356Jun 16 05:53 PM
Goldstein DanVP, Corporate ControllerJun 15Sale87.671,374120,4634,889Jun 16 05:55 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 15Sale87.719,720852,54125,112Jun 16 06:16 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 12Sale89.2919717,59034,832Jun 16 06:16 PM
Goldstein DanVP, Corporate ControllerJun 12Sale82.29423,4566,263Jun 16 05:55 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 12Sale89.291119,91116,889Jun 16 05:53 PM
Simon, ChristopherPresident & CEOJun 12Sale89.291,294115,541416,117Jun 16 05:51 PM
Basil Michelle LEVP and General CounselJun 12Sale89.2920318,12640,187Jun 16 06:19 PM
Goldstein DanVP, Corporate ControllerJun 09Sale97.1918718,1751,983Jun 10 06:04 PM
Goldstein DanVP, Corporate ControllerJun 08Option Exercise41.641,10646,0543,276Jun 10 06:04 PM
Goldstein DanVP, Corporate ControllerJun 08Sale98.951,189117,6472,170Jun 10 06:04 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 08Sale97.0332431,4385,714Jun 10 05:59 PM
Basil Michelle LEVP and General CounselJun 08Sale97.0368766,66016,376Jun 10 05:57 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 08Sale97.0363962,00212,695Jun 10 05:54 PM
Simon, ChristopherPresident & CEOJun 08Sale97.032,920283,328315,347Jun 10 05:52 PM
Goldstein DanVP, Corporate ControllerMay 18Sale101.7210110,2741,709May 19 06:10 PM
Simon, ChristopherPresident & CEOMay 15Sale100.441,008101,244303,757May 19 07:06 PM
Goldstein DanVP, Corporate ControllerMay 15Sale100.44424,2181,810May 19 06:10 PM
Llorens JosepSVP, Global ManufacturingMay 15Sale100.4410710,7472,663May 19 05:51 PM
Scanlan JacquelineSVP, Global Human ResourcesMay 15Sale100.4411011,0484,466May 19 05:34 PM
Basil Michelle LEVP and General CounselMay 15Sale100.4420320,38914,161May 19 05:20 PM
Burke William P. Mr.EVP, Chief Financial OfficerMay 15Sale100.4422122,19710,190May 19 05:10 PM
KROLL MARK WDirectorApr 09Option Exercise45.456,573298,74329,320Apr 13 05:12 PM
KROLL MARK WDirectorApr 09Sale102.0010,9021,112,00418,418Apr 13 05:12 PM
Goldstein DanVP, Corporate ControllerApr 08Sale97.1239938,7511,852Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 07Sale103.9120120,8862,251Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 06Option Exercise34.422,60789,7335,059Apr 08 05:10 PM
Goldstein DanVP, Corporate ControllerApr 06Sale101.622,607264,9232,452Apr 08 05:10 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 10Sale99.6320720,6234,383Mar 10 05:46 PM
Basil Michelle LEVP and General CounselMar 09Sale98.0039538,71014,364Mar 10 06:16 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 09Sale98.0011811,5644,590Mar 10 05:46 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 06Option Exercise38.431,29949,9216,007Mar 10 05:46 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 06Sale100.501,299130,5504,708Mar 10 05:46 PM